185 related articles for article (PubMed ID: 17106526)
1. Clinical, morphological and immunohistochemical aspects in laryngeal premalignant lesions.
Anghelina F; Ioniţă E; Popescu CF; Ioniţă I; Mogoantă C; Ciolofan S; Mogoantă L
Rom J Morphol Embryol; 2006; 47(2):169-74. PubMed ID: 17106526
[TBL] [Abstract][Full Text] [Related]
2. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
[TBL] [Abstract][Full Text] [Related]
3. [An immunohistochemical study of proliferating cell nuclear antigen (PCNA) and MIB-1 in epithelial hyperplasia and dysplasia of the vocal cords].
Urano M; Iwata S; Takasu A; Mori S; Sakurai K; Katoh H; Yamamoto S; Kasahara M; Kuroda M; Hakuno T
Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):395-401. PubMed ID: 8934774
[TBL] [Abstract][Full Text] [Related]
4. [Expression of proliferating cell nuclear antigen (PCNA) in premalignant lesions of laryngeal epithelium].
Zhou G; Lin D; Liang C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):206-8. PubMed ID: 8745457
[TBL] [Abstract][Full Text] [Related]
5. PCNA--a cell proliferation marker in vocal chord cancer. Part I: Premalignant laryngeal lesions.
Pignataro LD; Broich G; Lavezzi AM; Biondo B; Ottaviani F
Anticancer Res; 1995; 15(4):1517-20. PubMed ID: 7654040
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of p53 protein in benign and malignant laryngeal epithelial lesions.
Poljak M; Gale N; Kambic V; Ferluga D; Fischinger J
Anticancer Res; 1996; 16(4A):1947-51. PubMed ID: 8712726
[TBL] [Abstract][Full Text] [Related]
7. Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions.
Papadimitrakopoulou VA; Liu DD; Mao L; Shin DM; El-Naggar A; Ibarguen H; Lee JJ; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1605-10. PubMed ID: 12496051
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of cathepsin D in laryngeal epithelial lesions: correlation with CD44 expression, p53 and Rb status and proliferation associated indices.
Goussia A; Ioachim E; Peschos D; Assimakopoulos D; Vougiouklakis T; Skevas A; Agnantis N
Anticancer Res; 1999; 19(4B):3055-60. PubMed ID: 10652592
[TBL] [Abstract][Full Text] [Related]
9. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
10. Immunohistological comparison of the World Health Organization (WHO) and Ljubljana classifications on the grading of preneoplastic lesions of the larynx.
Sengiz S; Pabuççuoğlu U; Sarioğlu S
Pathol Res Pract; 2004; 200(3):181-8. PubMed ID: 15200269
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
[TBL] [Abstract][Full Text] [Related]
12. Is severe dysplasia the same lesion as carcinoma in situ? 10-Year follow-up of laryngeal precancerous lesions.
Zhang HK; Liu HG
Acta Otolaryngol; 2012 Mar; 132(3):325-8. PubMed ID: 22229875
[TBL] [Abstract][Full Text] [Related]
13. Evolution of precancerous laryngeal lesions: a clinicopathologic study with long-term follow-up on 259 patients.
Gallo A; de Vincentiis M; Della Rocca C; Moi R; Simonelli M; Minni A; Shaha AR
Head Neck; 2001 Jan; 23(1):42-7. PubMed ID: 11190857
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical studies of the antibody pattern (tumor markers) of the larynx].
Meister EF; Goertchen R
Laryngorhinootologie; 1994 Dec; 73(12):647-50. PubMed ID: 7840828
[TBL] [Abstract][Full Text] [Related]
15. [Precancerous diseases and the early recognition of pharyngeal and laryngeal carcinomas].
Hanson J; Bruchmüller W; Nischwitz AS
Arch Geschwulstforsch; 1989; 59(2):99-105. PubMed ID: 2719538
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of p27 is correlated with progression in precancerous lesions of the larynx.
Hirai T; Hayashi K; Takumida M; Ueda T; Hirakawa K; Yajin K
Auris Nasus Larynx; 2003 May; 30(2):163-8. PubMed ID: 12753988
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence investigations to classify malignant laryngeal lesions in vivo.
Rydell R; Eker C; Andersson-Engels S; Krogdahl A; Wahlberg P; Svanberg K
Head Neck; 2008 Apr; 30(4):419-26. PubMed ID: 18172880
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of 100 cases of precancerous laryngeal lesions].
Li H; Cui X; Guan C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(5):302-4. PubMed ID: 8762514
[TBL] [Abstract][Full Text] [Related]
19. Some experience with in vivo staining of early laryngeal cancer in Jakarta, Indonesia.
Kurniawan AN; Handikin LS
Cancer Detect Prev; 1981; 4(1-4):313-7. PubMed ID: 6187454
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study on precancerous laryngeal lesions: long-term follow-up.
Ricci G; Molini E; Faralli M; Simoncelli C
Acta Otorhinolaryngol Ital; 2003 Oct; 23(5):362-7. PubMed ID: 15108486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
